A 22-year-old kidney transplant recipient presenting with new MAHA
This patient case has been developed with the assistance of Dr. Anja Gäckler (Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany). This program was supported by Alexion Pharmaceuticals.
The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.
For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different product labeling according to geographical location. Within Europe, full prescribing information is available from the European Medicines Agency and Electronic Medicines Compendium:
• www.ema.europa.eu/en/documents/product-information/ultomiris-epar-product-information_en.pdf
• www.ema.europa.eu/en/documents/product-information/soliris-epar-product-information_en.pdf
• www.medicines.org.uk/emc/product/11945
• www.medicines.org.uk/emc/product/362
All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for healthcare professionals. To proceed, please confirm that you are a healthcare professional.
Some drugs may not be available or licensed in your country/region. Please refer to your local medicines regulatory agency for more information.
Material ID: INT/ULT-a/0098
Modules
A 22-year-old kidney transplant recipient presenting with new MAHA
A 5-year-old boy with hypertension and AKI
A 52-year-old man with AKI and malignant hypertension
A woman presenting with deterioration of renal function post-kidney transplantation
